Therefore, we speculate that the TERT de novo c.2286 + 1G/A mutation can directly interfere with TERT enzymatic activity, resulting in telomere shortening, dyskeratosis congenita, and PSVD. This evidence concerns the gene TERT and dyskeratosis congenita.